{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:48:58Z","timestamp":1780325338622,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011097","name":"Universiteit Maastricht CARIM School for Cardiovascular Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jtha.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:31:14Z","timestamp":1697848274000},"page":"410-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In\u00a0vitro and ex\u00a0vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency"],"prefix":"10.1016","volume":"22","author":[{"given":"Alice M.","family":"Todaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Toffanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Serino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Bulato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Gemmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman M.","family":"Hackeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Castoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.10.007_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ijlh.12508","article-title":"Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders","volume":"38","author":"Dahlb\u00e4ck","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2023.10.007_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0021-9258(19)86294-4","article-title":"The role of phospholipids and factor Va in the prothrombinase complex","volume":"255","author":"Rosing","year":"1980","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.10.007_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/384066a0","article-title":"Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V","volume":"384","author":"Cui","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.10.007_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0039-1687906","article-title":"A\u00a0comprehensive overview of coagulation factor V and congenital factor V deficiency","volume":"45","author":"Tabibian","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2141.1998.01077.x","article-title":"Symptoms of inherited factor V deficiency in 35 Iranian patients","volume":"103","author":"Lak","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.10.007_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2009-08-237719","article-title":"Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms","volume":"115","author":"Duckers","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib7","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V92.9.3035","article-title":"Secretable human platelet-derived factor V originates from the plasma pool","volume":"92","author":"Camire","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1538-7836.2005.01157.x","article-title":"Megakaryocytes endocytose and subsequently modify human factor V in\u00a0vivo to form the entire pool of a unique platelet-derived cofactor","volume":"3","author":"Gould","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jth.13559","article-title":"The C-terminus of tissue factor pathway inhibitor-alpha inhibits factor V activation by protecting the Arg1545 cleavage site","volume":"15","author":"van Doorn","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib10","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.10.007_bib11","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib12","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPI\u03b1","volume":"123","author":"Vincent","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.10.007_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/hae.13465","article-title":"\u201cIn\u00a0vitro\u201d correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate","volume":"24","author":"Bulato","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.10.007_bib14","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1111\/j.1537-2995.2012.03663.x","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2023.10.007_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13102","article-title":"Management of intracranial hemorrhage in severe factor V deficiency and definitive treatment with liver transplantation","volume":"22","author":"DesPain","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtha.2023.10.007_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112059","article-title":"Cell therapy for factor V deficiency: an approach based on human decidua mesenchymal stem cells","volume":"142","author":"Serrano","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtha.2023.10.007_bib17","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2013-04-499657","article-title":"Antisense-based RNA therapy of factor V deficiency: in\u00a0vitro and ex\u00a0vivo rescue of a F5 deep-intronic splicing mutation","volume":"122","author":"Nuzzo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/hae.12554","article-title":"Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency","volume":"21","author":"Nuzzo","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.10.007_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/hae.14104","article-title":"Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR\/Cas9-mediated gene editing","volume":"26","author":"Nakamura","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.10.007_bib20","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1055\/a-1987-5978","article-title":"Analysis of 363 genetic variants in F5 via an interactive web database reveals new insights into FV deficiency and FV Leiden","volume":"7","author":"Efthymiou","year":"2023","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2023.10.007_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1403","article-title":"Nonsense-mediated decay approaches the clinic","volume":"36","author":"Holbrook","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2023.10.007_bib22","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1093\/nar\/gku663","article-title":"New insights into the incorporation of natural suppressor tRNAs at stop codons in Saccharomyces cerevisiae","volume":"42","author":"Blanchet","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2023.10.007_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/wrna.95","article-title":"Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases","volume":"2","author":"Keeling","year":"2011","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.jtha.2023.10.007_bib24","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.3390\/ijms21249449","article-title":"Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches","volume":"21","author":"Lombardi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.10.007_bib25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.jtha.2023.10.007_bib26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/13543784.2020.1828862","article-title":"ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease","volume":"29","author":"Kerem","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jtha.2023.10.007_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/jpet.120.265595","article-title":"ELX-02 generates protein via premature stop codon read-through without inducing native stop codon read-through proteins","volume":"374","author":"Crawford","year":"2020","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jtha.2023.10.007_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.10.007_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020599118","article-title":"Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms","volume":"118","author":"Ng","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.10.007_bib30","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41467-020-15140-z","article-title":"2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations","volume":"11","author":"Trzaska","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.10.007_bib31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ymthe.2023.01.014","article-title":"Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis","volume":"31","author":"Leroy","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2023.10.007_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1172-7-58","article-title":"Rescue of nonsense mutations by amlexanox in human cells","volume":"7","author":"Gonzalez-Hilarion","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2023.10.007_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","article-title":"Sense from nonsense: therapies for premature stop codon diseases","volume":"18","author":"Bidou","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jtha.2023.10.007_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1538-7836.2006.01915.x","article-title":"International Factor VII Deficiency Study Group. Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII","volume":"4","author":"Pinotti","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib35","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jth.13443","article-title":"Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency","volume":"14","author":"Branchini","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.23404","article-title":"Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B","volume":"39","author":"Ferrarese","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2023.10.007_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3324\/haematol.2018.212118","article-title":"Variable readthrough responsiveness of nonsense mutations in hemophilia A","volume":"105","author":"Martorell","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.10.007_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1046\/j.1365-2141.2001.03016.x","article-title":"Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency","volume":"114","author":"van Wijk","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.10.007_bib39","first-page":"145","article-title":"Gene analysis of five inherited factor V deficiency cases. Article in Chinese","volume":"29","author":"Cao","year":"2008","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.jtha.2023.10.007_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2516.2009.02048.x","article-title":"Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency","volume":"15","author":"Delev","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.10.007_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MBC.0b013e32832545db","article-title":"A\u00a0novel in-frame deletion in the factor V C1 domain associated with severe coagulation factor V deficiency in a Korean family","volume":"20","author":"Song","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2023.10.007_bib42","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.3324\/haematol.2019.232587","article-title":"Profiling the mutational landscape of coagulation factor V deficiency","volume":"105","author":"Paraboschi","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.10.007_bib43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bjh.14262","article-title":"Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia","volume":"175","author":"Radu","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.10.007_bib44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1538-7836.2010.03743.x","article-title":"Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals","volume":"8","author":"Maurissen","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1538-7836.2011.04237.x","article-title":"Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma","volume":"9","author":"Castoldi","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib46","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1093\/bioinformatics\/btp583","article-title":"Inferring relative proportions of DNA variants from sequencing electropherograms","volume":"25","author":"Carr","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtha.2023.10.007_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.10.007_bib48","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A\u00a0common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.ATV.0000109750.34073.f6","article-title":"Modulation of factor V levels in plasma by polymorphisms in the C2 domain","volume":"24","author":"Scanavini","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2023.10.007_bib50","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1073\/pnas.1605336113","article-title":"Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression","volume":"113","author":"Roy","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.10.007_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","article-title":"To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases","volume":"37","author":"Supek","year":"2021","journal-title":"Trends Genet"},{"key":"10.1016\/j.jtha.2023.10.007_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102592","article-title":"Features and factors that dictate if terminating ribosomes cause or counteract nonsense-mediated mRNA decay","volume":"298","author":"Embree","year":"2022","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.10.007_bib53","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2014-07-589580","article-title":"Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency","volume":"125","author":"Bouchard","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"Guthrie","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.jtha.2023.10.007_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jtha.2023.10.007_bib56","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2022.281279","article-title":"Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association","volume":"108","author":"Testa","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.10.007_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187930","article-title":"Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases","volume":"12","author":"Benhabiles","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2023.10.007_bib58","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acsmedchemlett.9b00609","article-title":"Pharmacophore-based design of new chemical scaffolds as translational readthrough-inducing drugs (TRIDs)","volume":"11","author":"Tutone","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jtha.2023.10.007_bib59","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/acsmedchemlett.1c00349","article-title":"Reducing the toxicity of designer aminoglycosides as nonsense mutation readthrough agents for therapeutic targets","volume":"12","author":"Popadynec","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jtha.2023.10.007_bib60","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1038\/s41467-021-24575-x","article-title":"A\u00a0small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.10.007_bib61","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V67.6.1639.1639","article-title":"Biology of human megakaryocyte factor V","volume":"67","author":"Gewirtz","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.007_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2141.2004.05279.x","article-title":"Factor-V expression in platelets from human megakaryocytic culture","volume":"128","author":"Giampaolo","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.10.007_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","article-title":"Readthrough compounds for nonsense mutations: bridging the translational gap","volume":"29","author":"Spelier","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jtha.2023.10.007_bib64","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/jth.12417","article-title":"The factor V light chain mediates the binding and endocytosis of plasma-derived factor V by megakaryocytes","volume":"11","author":"Bouchard","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib65","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/jth.15274","article-title":"Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besan\u00e7on)","volume":"19","author":"Castoldi","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.007_bib66","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1538-7836.2005.01430.x","article-title":"Determinants of the APTT- and ETP-based APC sensitivity tests","volume":"3","author":"de Visser","year":"2005","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:42:04Z","timestamp":1761536524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623007754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1538783623007754"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.007","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro and ex\u00a0vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}